ATE464378T1 - Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und - differenzierung - Google Patents

Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und - differenzierung

Info

Publication number
ATE464378T1
ATE464378T1 AT01940910T AT01940910T ATE464378T1 AT E464378 T1 ATE464378 T1 AT E464378T1 AT 01940910 T AT01940910 T AT 01940910T AT 01940910 T AT01940910 T AT 01940910T AT E464378 T1 ATE464378 T1 AT E464378T1
Authority
AT
Austria
Prior art keywords
muscle
muscle mass
acrp30
globular head
methods
Prior art date
Application number
AT01940910T
Other languages
English (en)
Inventor
Harvey Lodish
Joachim Fruebis
Tsu-Shuen Tsao
Bernard Bihain
Original Assignee
Serono Genetics Inst Sa
Whitehead Biomedical Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Genetics Inst Sa, Whitehead Biomedical Inst filed Critical Serono Genetics Inst Sa
Application granted granted Critical
Publication of ATE464378T1 publication Critical patent/ATE464378T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01940910T 2000-05-31 2001-05-22 Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und - differenzierung ATE464378T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20825100P 2000-05-31 2000-05-31
US23973500P 2000-10-11 2000-10-11
PCT/IB2001/001126 WO2001092330A2 (en) 2000-05-31 2001-05-22 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation

Publications (1)

Publication Number Publication Date
ATE464378T1 true ATE464378T1 (de) 2010-04-15

Family

ID=26903041

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01940910T ATE464378T1 (de) 2000-05-31 2001-05-22 Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und - differenzierung

Country Status (9)

Country Link
US (2) US7405193B2 (de)
EP (1) EP1294866B1 (de)
JP (1) JP2003535104A (de)
AT (1) ATE464378T1 (de)
AU (2) AU781253B2 (de)
CA (1) CA2410758A1 (de)
DE (1) DE60141827D1 (de)
IL (2) IL153200A0 (de)
WO (1) WO2001092330A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003223070A1 (en) * 2002-05-17 2003-12-02 Serono Genetics Institute S.A. Obg3 fragments inhibiting the conversion of active obg3 into less active obg3 and other compositions for treatment of metabolic disorders
AU2003225410A1 (en) 2003-03-21 2004-10-11 Academisch Ziekenhuis Leiden Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
WO2005113599A1 (en) * 2004-05-21 2005-12-01 Xencor, Inc. C1q family member proteins with altered immunogenicity
PT2049664E (pt) 2006-08-11 2012-01-03 Prosensa Technologies Bv Oligonucleotídeos de cadeia simples complementares dos elementos repetitivos para tratar perturbações genéticas associadas à instabilidade das repetições do adn
DK2167136T3 (en) * 2007-07-12 2016-07-25 Biomarin Tech Bv Molecules for targeting compounds at different selected organs or tissues
WO2009008725A2 (en) * 2007-07-12 2009-01-15 Prosensa Technologies B.V. Molecules for targeting compounds to various selected organs, tissues or tumor cells
PL2203173T3 (pl) 2007-10-26 2016-06-30 Academisch Ziekenhuis Leiden Środki i sposoby przeciwdziałania zaburzeniom mięśni
USRE48468E1 (en) 2007-10-26 2021-03-16 Biomarin Technologies B.V. Means and methods for counteracting muscle disorders
EP2088156A1 (de) 2008-02-08 2009-08-12 Institut Pasteur Verwendung von Adiponektin zur Diagnose und/oder Behandlung von Presbyakusis
EP2119783A1 (de) 2008-05-14 2009-11-18 Prosensa Technologies B.V. Verfahren für effizientes Exon (44)-Skipping bei Duchenne-Muskeldystrophie und entsprechende Mittel
WO2010123369A1 (en) 2009-04-24 2010-10-28 Prosensa Technologies B.V. Oligonucleotide comprising an inosine for treating dmd
JP6141018B2 (ja) 2009-12-24 2017-06-07 バイオマリン テクノロジーズ ベー．フェー． 炎症性障害を治療するための分子
JP2015509922A (ja) 2012-01-27 2015-04-02 プロセンサ テクノロジーズ ビー．ブイ．Ｐｒｏｓｅｎｓａ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｂ．Ｖ． デュシェンヌ型及びベッカー型筋ジストロフィーの治療のための改善された特徴を有するｒｎａ調節オリゴヌクレオチド
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
JP6539511B2 (ja) * 2015-06-17 2019-07-03 花王株式会社 運動機能の判定用マーカー
NL2015032B1 (en) 2015-06-26 2017-01-24 Vitalnext B V Compositions and methods for the treatment of malnutrition.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
FR2767135B1 (fr) * 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
DE98950411T1 (de) * 1997-10-29 2005-10-20 Otsuka Pharma Co Ltd Zusammensetzung zur Inhibierung der Proliferation glatter Muskulatur, Verfahren zur Diagnose von Arteriosklerose, sowie Kits hierzu
US6989367B2 (en) 2000-01-14 2006-01-24 Genset S.A. OBG3 globular head and uses thereof
JP4698914B2 (ja) * 2000-01-14 2011-06-08 セローノ ジェネティクス インスティテュート ソシエテ アノニム Ｏｂｇ３およびこれを使用してボディーマスを減少させるための方法
US20020058617A1 (en) 2000-01-14 2002-05-16 Joachim Fruebis OBG3 globular head and uses thereof for decreasing body mass
US6566332B2 (en) 2000-01-14 2003-05-20 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
US6579852B2 (en) 2000-01-14 2003-06-17 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
US7338787B2 (en) 2000-01-14 2008-03-04 Serono Genetics Institute S.A. Nucleic acids encoding OBG3 globular head and uses thereof
EP1355657A2 (de) 2001-02-02 2003-10-29 Genset Gssp3 polynucleotide und polypeptide und deren verwendung
US6867189B2 (en) 2001-07-26 2005-03-15 Genset S.A. Use of adipsin/complement factor D in the treatment of metabolic related disorders
IL161234A0 (en) 2001-10-12 2004-09-27 Genset Sa Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof

Also Published As

Publication number Publication date
IL153200A (en) 2010-05-17
AU781253B2 (en) 2005-05-12
EP1294866B1 (de) 2010-04-14
AU2005203365A1 (en) 2005-08-25
US20080274971A1 (en) 2008-11-06
JP2003535104A (ja) 2003-11-25
DE60141827D1 (de) 2010-05-27
EP1294866A2 (de) 2003-03-26
AU2005203365B2 (en) 2008-02-14
US7405193B2 (en) 2008-07-29
WO2001092330A2 (en) 2001-12-06
CA2410758A1 (en) 2001-12-06
IL153200A0 (en) 2003-07-06
US20060035824A1 (en) 2006-02-16
WO2001092330A3 (en) 2002-08-22
AU7439801A (en) 2001-12-11

Similar Documents

Publication Publication Date Title
ATE464378T1 (de) Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und - differenzierung
ATE309358T1 (de) Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein
ATE245416T1 (de) Neue fettanaloge zur behandlung von diabetes
ATE342964T1 (de) Rekombinante alpha-l-iduronisase, deren herstellungs- und aufreinigungsverfahren, und behandlung von durch diese hervorgerufene mangelerkrankungen
DE69927507D1 (de) Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung
ATE356113T1 (de) Probucolbernsteinsäureester zur hemmung der expression von vcam-1
CA2288445A1 (en) 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
EP1549767A4 (de) Modulation der expression von forkhead-box o1a
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
ATE248911T1 (de) Magnetische partikel zur reinigung von nukleinsäuren
IL160157A (en) Combination motif immune stimulatory oligonucleotides with improved activity
ATE340515T1 (de) Fraktionierung und behandlung von ölsaatmehl
EA200201214A1 (ru) Замещенные тиоацетамиды
BG105012A (en) N-linked sulphonamides of n-heterocyclic carboxylic acids or carboxylic isosteres
ATE459360T1 (de) Phosphoantigen enthaltene zusammensetzungen zur regulierung von immunereaktionen
DE60307237D1 (de) Verwendung von tyrosine-kinase inhibitoren zur behandlung von cns krankheiten
HK1040402A1 (zh) 使用乳粘素(lactadherin)或其變體的的方法及其組合物
ATE317381T1 (de) Sulfonamid-substituierte asparaginsäuren als inhibitoren von interleukin-1beta-konvertierenden enzymen
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
ATE322244T1 (de) Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen
DE69534386D1 (de) Freigabe von intrazellulärem material
ATE409469T1 (de) Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen
WO2003064460A8 (en) Two gonadotropin releasing hormones and a method to isolate the same
ATE399551T1 (de) Hilfsmittel und methoden zur transdermalen applikation von felodipin
NZ329018A (en) Extracting glycogen from Green Shell Mussels and the use of the glycogen as a food supplement or additive or in the treatment of inflammatory diseases such as arthritis.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties